ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $113,000 | +2.7% | 20,000 | 0.0% | 0.03% | +3.8% |
Q2 2016 | $110,000 | -68.5% | 20,000 | -57.4% | 0.03% | -69.0% |
Q1 2016 | $349,000 | -22.4% | 47,000 | -13.3% | 0.08% | -20.0% |
Q4 2015 | $450,000 | -50.3% | 54,200 | -46.0% | 0.10% | -53.9% |
Q3 2015 | $905,000 | +143.3% | 100,400 | +223.9% | 0.23% | +171.4% |
Q2 2015 | $372,000 | – | 31,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |